» Articles » PMID: 31894516

Prediagnostic Symptoms and Signs of Adult Glioma: the Patients' View

Overview
Journal J Neurooncol
Publisher Springer
Date 2020 Jan 3
PMID 31894516
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Little is known about the symptoms glioma patients experience in the year before diagnosis, either or not resulting in health care usage. This study aimed to determine the incidence of symptoms glioma patients experienced in the year prior to diagnosis, and subsequent visits to a general practitioner (GP).

Methods: Glioma patients were asked to complete a 30-item study-specific questionnaire focusing on symptoms they experienced in the 12 months before diagnosis. For each indicated symptom, patients were asked whether they consulted the GP for this issue.

Results: Fifty-nine patients completed the questionnaires, 54 (93%) with input of a proxy. The median time since diagnosis was 4 months (range 1-12). The median number of symptoms experienced in the year before diagnosis was similar between gliomas with favourable and poor prognosis, i.e. 6 (range 0-24), as were the five most frequently mentioned problems: fatigue (n = 34, 58%), mental tiredness (n = 30, 51%), sleeping disorder (n = 24, 41%), headache (n = 23, 39%) and stress (n = 20, 34%). Twenty-six (44%) patients visited the GP with at least one issue. Patients who did consult their GP reported significantly more often muscle weakness (11 vs 3, p = 0.003) than patients who did not, which remained significant after correction for multiple testing, which was not the case for paralysis in hand/leg (10 vs 4), focussing (11 vs 6) or a change in awareness (9 vs 4).

Conclusions: Glioma patients experience a range of non-specific problems in the year prior to diagnosis, but only patients who consult the GP report more often neurological problems.

Citing Articles

Circadian rhythm related genes signature in glioma for drug resistance prediction: a comprehensive analysis integrating transcriptomics and machine learning.

Liao J, Duan Y, Xu X, Liu Y, Zhan C, Xiao G Discov Oncol. 2025; 16(1):119.

PMID: 39909964 PMC: 11799505. DOI: 10.1007/s12672-025-01863-2.


Knockdown of CENPF induces cell cycle arrest and inhibits epithelial‑mesenchymal transition progression in glioma.

Li J, Liu L, Zong G, Yang Z, Zhang D, Zhao B Oncol Lett. 2024; 29(1):61.

PMID: 39611064 PMC: 11602827. DOI: 10.3892/ol.2024.14807.


Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study.

Fischl A, Gerken M, Roos P, Haedenkamp T, Hillberg A, Klinkhammer-Schalke M Neurooncol Pract. 2023; 10(5):446-453.

PMID: 37720387 PMC: 10502780. DOI: 10.1093/nop/npad023.


Deep learning-assisted radiomics facilitates multimodal prognostication for personalized treatment strategies in low-grade glioma.

Rauch P, Stefanits H, Aichholzer M, Serra C, Vorhauer D, Wagner H Sci Rep. 2023; 13(1):9494.

PMID: 37302994 PMC: 10258197. DOI: 10.1038/s41598-023-36298-8.


Classification and Diagnosis of Adult Glioma: A Scoping Review.

Byun Y, Park C Brain Neurorehabil. 2023; 15(3):e23.

PMID: 36742083 PMC: 9833487. DOI: 10.12786/bn.2022.15.e23.


References
1.
van Kessel E, Baumfalk A, van Zandvoort M, Robe P, Snijders T . Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment. J Neurooncol. 2017; 134(1):9-18. PMC: 5543199. DOI: 10.1007/s11060-017-2503-z. View

2.
Peeters M, Dirven L, Koekkoek J, Numans M, Taphoorn M . Prediagnostic presentations of glioma in primary care: a case-control study. CNS Oncol. 2019; 8(3):CNS44. PMC: 6880303. DOI: 10.2217/cns-2019-0015. View

3.
Ozawa M, Brennan P, Zienius K, Kurian K, Hollingworth W, Weller D . Symptoms in primary care with time to diagnosis of brain tumours. Fam Pract. 2018; 35(5):551-558. PMC: 6142711. DOI: 10.1093/fampra/cmx139. View

4.
Bosma I, Vos M, Heimans J, Taphoorn M, Aaronson N, Postma T . The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol. 2006; 9(1):53-62. PMC: 1828106. DOI: 10.1215/15228517-2006-012. View

5.
Iuchi T, Hasegawa Y, Kawasaki K, Sakaida T . Epilepsy in patients with gliomas: incidence and control of seizures. J Clin Neurosci. 2014; 22(1):87-91. DOI: 10.1016/j.jocn.2014.05.036. View